UK markets closed

Marinus Pharmaceuticals, Inc. (MRNS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.5150+0.1050 (+7.45%)
As of 03:19PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts11111111
Avg. Estimate-0.66-0.6-2.19-1.29
Low estimate-0.79-0.68-2.98-2.31
High estimate-0.61-0.48-1.7-0.65
Year ago EPS-0.67-0.61-2.63-2.19
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts11111111
Avg. Estimate9.12M9.59M40.84M61.88M
Low estimate7.3M7.91M33.22M41.5M
High estimate15.26M12.1M55.3M127.7M
Year ago sales10.38M6.08M30.99M40.84M
Sales growth (year/est)-12.10%57.70%31.80%51.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.72-0.72-0.66-0.62
Actual EPS-0.67-0.61-0.61-0.74
Difference0.050.110.05-0.12
Surprise %6.90%15.30%7.60%-19.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.66-0.6-2.19-1.29
7 days ago-0.66-0.6-2.19-1.29
30 days ago-0.63-0.58-2.36-1.87
60 days ago-0.58-0.56-2.27-1.65
90 days ago-0.58-0.56-2.27-1.63
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days5478
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMRNSIndustrySector(s)S&P 500
Current qtr.1.50%N/AN/AN/A
Next qtr.1.60%N/AN/AN/A
Current year16.70%N/AN/AN/A
Next year41.10%N/AN/AN/A
Next 5 years (per annum)20.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A